Correlation Between Sonnet Biotherapeutics and Genelux Common

Can any of the company-specific risk be diversified away by investing in both Sonnet Biotherapeutics and Genelux Common at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sonnet Biotherapeutics and Genelux Common into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Sonnet Biotherapeutics Holdings and Genelux Common, you can compare the effects of market volatilities on Sonnet Biotherapeutics and Genelux Common and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sonnet Biotherapeutics with a short position of Genelux Common. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sonnet Biotherapeutics and Genelux Common.

Diversification Opportunities for Sonnet Biotherapeutics and Genelux Common

0.47

Correlation Coefficient

Sonnet Biotherapeutics  Genelux Common

Very weak diversification

The 3 months correlation between Sonnet and Genelux is 0.47. Overlapping area represents the amount of risk that can be diversified away by holding Sonnet Biotherapeutics Holding and Genelux Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Genelux Common and Sonnet Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sonnet Biotherapeutics Holdings are associated (or correlated) with Genelux Common. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Genelux Common has no effect on the direction of Sonnet Biotherapeutics i.e., Sonnet Biotherapeutics and Genelux Common go up and down completely randomly.

Pair Corralation between Sonnet Biotherapeutics and Genelux Common

Given the investment horizon of 90 days Sonnet Biotherapeutics Holdings is expected to under-perform the Genelux Common. In addition to that, Sonnet Biotherapeutics is 1.37 times more volatile than Genelux Common. It trades about -0.23 of its total potential returns per unit of risk. Genelux Common is currently generating about 0.09 per unit of volatility. If you would invest  255.00  in Genelux Common on October 25, 2024 and sell it today you would earn a total of  60.00  from holding Genelux Common or generate 23.53% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Sonnet Biotherapeutics Holding  vs.  Genelux Common

Sonnet Biotherapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Sonnet Biotherapeutics Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in February 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Genelux Common

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Genelux Common are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak essential indicators, Genelux Common showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Sonnet Biotherapeutics and Genelux Common

The main advantage of trading using opposite Sonnet Biotherapeutics and Genelux Common positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sonnet Biotherapeutics position performs unexpectedly, Genelux Common can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genelux Common will offset losses from the drop in Genelux Common's long position.

The idea behind Sonnet Biotherapeutics Holdings and Genelux Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.